Evidence map›Paper›PMID 34332614›Full record

ArticleRadiation oncology (London, England)2021

Comparison of the composition of lymphocyte subpopulations in non-relapse and relapse patients with squamous cell carcinoma of the head and neck before, during radiochemotherapy and in the follow-up period: a multicenter prospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).

Minli Niu, Stephanie E Combs, Annett Linge, Mechthild Krause, Michael Baumann, Fabian Lohaus, Nadja Ebert, Ingeborg Tinhofer, Volker Budach, Jens von der Grün and 3 more

Registry-linked trialOpen access · goldAbstract readMulticenter Study
In one paragraph

Article in Radiation oncology (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02059668 (Observational Study on Biomarkers in Head and Neck Cancer), which is not on this map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02059668 completednot on this map

Observational Study on Biomarkers in Head and Neck Cancer

TypeobservationalSponsorTechnische Universität DresdenRan2014 to 2022Enrolled588ConditionsHead and Neck CancerArmsBiomarker analyses head & neck cancer tissue, blood specimen
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Low Pretreatment CD4International journal of molecular sciences · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Minli NiuCenter for Translational Cancer Research (TranslaTUM), Radiation Immuno-Oncology Group, Klinikum rechts der isar, TU München (TUM), Einsteinstr. 25, 81675, Munich, Germany. minli.niu@tum.de.ORCID http://orcid.org/0000-0003-3870-6140
Stephanie E CombsDepartment of Radiation Oncology, Klinikum rechts der isar, TUM, Munich, Germany.
Annett LingeGerman Cancer Research Center (DKFZ), Heidelberg, Germany.
Mechthild KrauseGerman Cancer Research Center (DKFZ), Heidelberg, Germany.
Michael BaumannGerman Cancer Research Center (DKFZ), Heidelberg, Germany.
Fabian LohausGerman Cancer Research Center (DKFZ), Heidelberg, Germany.
Nadja EbertGerman Cancer Research Center (DKFZ), Heidelberg, Germany.
Ingeborg TinhoferGerman Cancer Research Center (DKFZ), Heidelberg, Germany.
Volker BudachGerman Cancer Research Center (DKFZ), Heidelberg, Germany.
Jens von der GrünDepartment of Radiotherapy and Oncology, Goethe University, Frankfurt, Germany.
Franz RödelDepartment of Radiotherapy and Oncology, Goethe University, Frankfurt, Germany.
Anca-Ligia GrosuGerman Cancer Research Center (DKFZ), Heidelberg, Germany.
Gabriele MulthoffCenter for Translational Cancer Research (TranslaTUM), Radiation Immuno-Oncology Group, Klinikum rechts der isar, TU München (TUM), Einsteinstr. 25, 81675, Munich, Germany.
German Cancer Research Center · DEGoethe University Frankfurt · DETUM Klinikum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRadiochemotherapy (RCT) has been shown to induce changes in immune cell homeostasis which might affect antitumor immune responses. In the present study, we aimed to compare the composition and kinetics of major lymphocyte subsets in the periphery of patients with non-locoregional recurrent (n = 23) and locoregional recurrent (n = 9) squamous cell carcinoma of the head and neck (SCCHN) upon primary RCT.

methodsEDTA-blood of non-locoregional recurrent SCCHN patients was collected before (t0), after application of 20-30 Gy (t1), in the follow-up period 3 (t2) and 6 months (t3) after RCT. In patients with locoregional recurrence blood samples were taken at t0, t1, t2 and at the time of recurrence (t5). EDTA-blood of age-related, healthy volunteers (n = 22) served as a control (Ctrl). Major lymphocyte subpopulations were phenotyped by multiparameter flow cytometry.

resultsPatients with non-recurrent SCCHN had significantly lower proportions of CD19

conclusionMonitoring the kinetics of lymphocyte subpopulations especially activatory NK cells before and after RCT might provide a clue with respect to the development of an early locoregional recurrence in patients with SCCHN. However, studies with larger patient cohorts are needed.

trial registrationObservational Study on Biomarkers in Head and Neck Cancer (HNprädBio), NCT02059668. Registered on 11 February 2014, https://clinicaltrials.gov/ct2/show/NCT02059668 .

Indexed as

AdultAgedAged, 80 and overCase-Control StudiesCD8-Positive T-LymphocytesChemoradiotherapyFemaleFollow-Up StudiesHead and Neck NeoplasmsHumansKiller Cells, NaturalLymphocyte SubsetsMaleMiddle AgedNeoplasm Recurrence, LocalPrognosisImmunophenotypingLymphocyte subpopulationsNK cell subsetsPrediction of locoregional recurrenceRadiochemotherapySCCHN

Identifiers

PMID34332614
PMCPMC8325802
OpenAlexW3120019523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.